Systematix Corporate Services Limited has appointed Mr. Ratnadeep Acharyya as Managing Director & CEO – IB (Investment Banking) and designated him as Senior Management Personnel of the Company, with effect from May 15, 2026. The appointment was approved by the Board of Directors through a circular resolution passed on May 15, 2026, based on the recommendation of the Nomination and Remuneration Committee, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is noted that this role does not form part of the Board of Directors of the Company.

Appointment Details

The key details of the appointment, as disclosed under Regulation 30 of the SEBI Listing Regulations, are summarised below:

Professional Profile

Mr. Ratnadeep Acharyya brings over 24 years of rich and diversified experience across Corporate and Investment Banking. He has previously worked with SBI Capital Markets, JM Financial, BNP Paribas, ICICI Securities, and ICICI Bank Treasury. Prior to joining the Systematix Group, he was a part of the SBICAPS Investment Banking leadership team and a member of the Executive Committee of SBICAPS since 2021. Before his tenure at SBICAPS, he headed the Financials Investment Banking team at JM Financial.

Capital Markets Expertise

Mr. Acharyya has extensive experience in Indian Equity Capital Markets, encompassing a wide range of transaction types. His areas of expertise include:

• IPOs and Follow-on offerings
• Rights Issues and Preferential Allotment
• Private Equity Syndication
• M&A Advisory

He has led several marquee IPOs, including those of Bajaj Housing Finance, LIC of India, ICICI Prudential Asset Management Company, Nippon AMC, Canara Robeco AMC, UTI AMC, Aditya Birla Sun Life AMC, International Gemological Institute, Aadhar Housing Finance, Afcons, Entero Healthcare, Muthoot Microfin, Jana SFB, and Tamilnad Mercantile Bank. Other notable transactions led by him include the IPOs of JSW Infrastructure, JSW Cement, Star Health Insurance, Canara HSBC Life Insurance, SBI Life, BSE Limited, NSDL Limited, CDSL Limited, and HUDCO.

Additional transactions include Rights Issues of Grasim Industries and Canara Bank, Bandhan Bank vendor placement, and QIPs of Polymed, Bajaj Finance, Bank of India, Indian Bank, Aether Limited, Mrs. Bectors Foods, Equitas SFB, Canara Bank, Bank of Baroda, IDFC First Bank, Yes Bank, State Bank of India, Vijaya Bank, and Edelweiss Financial Services, among others.

M&A Advisory Experience

Mr. Acharyya has been closely involved in several landmark M&A transactions. These include serving as exclusive Sell Side Advisor to shareholders on the Yes Bank Sale, the merger of SBI with its Associate Banks, the acquisition of Bhartiya Mahila Bank by SBI, and the three-way merger of Bank of Baroda, Vijaya Bank, and Dena Bank. Other notable M&A transactions include the NSE stake sale, Jio Payments Bank sell side advisory, and stake sale in SBI Life to Private Equity investors.

Academic Background

Mr. Ratnadeep Acharyya holds an MBA in Finance from Boston University, USA. He also holds a Masters in Economics from Cambridge University in the U.K., where he was a Cambridge Commonwealth Scholar.

Systematix Corporate Services Limited has announced the appointment of Ms. Rupam Lal Das as Joint Managing Director and Senior Management Personnel of the Company, effective May 08, 2026. The decision was taken through a circular resolution passed by the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is noted that Ms. Das's role as Joint Managing Director does not form part of the Board of Directors of the Company.

Appointment Details

The key details of the appointment, as disclosed in compliance with Regulation 30 of the SEBI Listing Regulations, are summarised below:

Professional Profile

Ms. Rupam Lal Das is an experienced Investment Banking professional with over 15 years of experience across Investment Banking, Capital Markets, M&A, Private Equity, and Healthcare & Pharmaceutical sector coverage. She was associated with JM Financial as Director – Healthcare & Pharmaceutical Coverage and has previously worked with reputed organisations including Anand Rathi Advisors, Edelweiss Financial Services, and Motilal Oswal Investment Advisors.

She has successfully led and executed multiple high-value IPOs, M&A, and fundraising transactions across the healthcare and pharmaceutical sectors, with strong industry relationships and extensive transaction experience.

Academic Background

Ms. Das holds strong academic credentials that complement her professional expertise:

• Post Graduate Program in Management (Finance & Operations) from Indian School of Business (ISB), Hyderabad
• Bachelor's degree in Electrical Engineering from BIT Sindri

Regulatory Compliance

The appointment disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024. The intimation was signed by Divyesh Badiyani, Company Secretary & Compliance Officer of Systematix Corporate Services Limited.